Atlas Trials

Advanced Hepatocellular Carcinoma (HCC)

26 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Advanced Hepatocellular Carcinoma (HCC)

RecordFirmDate
A Study of exoASO-STAT6 (CDK-004) in Patients With Advanced Hepatocellular Carcinoma (HCC) and Patients With Liver Metastases From EIther Primary Gastric Cancer or Colorectal Cancer (CRC) (NCT05375604)Codiak BioSciences2022-06-28
A Study of Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC) (NCT04985136)Jiangsu HengRui Medicine Co., Ltd.2021-09-26
Evaluate the Safety and Efficacy of Toripalimab Combined With Bevacizumab Versus Sorafenib Therapy for HCC (NCT04723004)Shanghai Junshi Bioscience Co., Ltd.2020-10-15
A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC) (NCT04344158)Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2020-08-11
Phase III Study of Toripalimab（JS001） Combined With Lenvatinib for Advanced HCC (NCT04523493)Shanghai Junshi Bioscience Co., Ltd.2020-06-29
MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients (NCT04212221)Zai Lab (Shanghai) Co., Ltd.2020-04-20
A Single-arm, Open-label, Multi-center Phase II Clinical Study to Evaluate the Safety and Efficacy of Toripalimab Injection (JS001) Combined With Bevacizumab as the First-line Therapy for Advanced Hepatocellular Carcinoma (HCC) (NCT04605796)Shanghai Junshi Bioscience Co., Ltd.2020-04-10
Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC) (NCT02906397)Abramson Cancer Center at Penn Medicine2017-03-30
The Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for HCC (NCT02814461)Shin Kong Wu Ho-Su Memorial Hospital2015-11-01
Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma (NCT02509169)Shenzhen SiBiono GeneTech Co.,Ltd2014-10-01
A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC (NCT01101906)Astellas Pharma Inc2011-01-10

Track Advanced Hepatocellular Carcinoma (HCC) automatically

Every clearance here is in the API, with alerts when new ones post.